← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2016Last known activity
Jul 28, 2021
Timeline
2000s
- Jun 1, 2001
EddingPharm Oncology Co., LTD.— Founded
2010s
- Jan 8, 2014
ACT Biotech, Inc— Acquired
Drugs by trial phase (13 distinct, 9 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 2 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (8)
- NCT04798781CollaboratorPhase 2Jul 28, 2021
- NCT03817411Lead sponsorPhase 2Jan 25, 2019
- NCT03600090Lead sponsorPhase 1Sep 1, 2018
- NCT03583125Lead sponsorPhase 1May 29, 2018
- NCT03538171Lead sponsorPhase 3May 15, 2018
- NCT03175497Lead sponsorPhase 1Jun 1, 2017
- NCT03085368CollaboratorPhase 2/Phase 3Mar 1, 2017
- NCT02833155Lead sponsorPhase 1Jul 1, 2016
Details
- Founded
- Hong Kong, HK Jun 1, 2001
- Last known activity
- Jul 28, 2021